Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative stress and transforming growth factor-β

被引:61
作者
Hogg, N
Browning, J
Howard, T
Winterford, C
Fitzpatrick, D
Gobé, G
机构
[1] Univ Queensland, Sch Med, Dept Pathol, Brisbane, Qld 4006, Australia
[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
[3] Griffith Univ, Sch Hlth Sci, Gold Coast 4215, Australia
来源
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 1999年 / 7卷 / 01期
关键词
apoptosis; endothelium; TGF-beta; 1; oxidative stress; hypoxia; serum deprivation;
D O I
10.3109/10623329909165310
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular endothelial cell apoptosis has previously been shown to play a role in the pathogenesis of hypertension-induced vessel deletion and damage. In the present in vitro study we analyse several possible relevant causative factors of vascular endothelial cell apoptosis, namely, serum deprivation and nutrient depletion, oxidative stress in the forms of hypoxia, hyperoxia or free radical damage, and altered levels of transforming growth factor-beta 1 (TGF-beta 1) protein. An established cell line, bovine aortic endothelial cells (BAEC), was maintained in complete growth medium (RPMI-1640 plus 15% fetal calf serum and antibiotics, abbreviated as RPMI) in 25cm(2) flasks or in 12-well plates on glass coverslips. Confluent but actively-growing cultures were treated with either hypoxia (PO2 of RPMI = 50mmHg), serum-free media (SFM), SFM plus hypoxia, hyperoxia (PO2 of RPMI = 450mmHg), hydrogen peroxide (H2O2, 1 mM) in SFM, or TGF-beta 1 protein (10ng/mL) in SFM. Appropriate control Cultures were used. BAEC were collected 48h or 72h after all treatments except for TGF-beta 1 and H2O2 treatments that were collected at 16-18h. Cell death was assessed using morphological characteristics or in situ end labeling (ISEL), cell proliferation assessed using proliferating cell nuclear antigen (PCNA), and TGF-beta 1 expression assessed using transcript levels or immunohistochemistry. All treatments significantly increased levels of apoptosis over control cultures (P<0.05), and decreased levels of cell proliferation. Treatment with TGF-beta 1 protein or SFM plus hypoxia induced greatest levels of apoptosis. TGF-beta 1 protein and transcript levels were decreased in treated cultures, results suggesting that a paracrine source of TGF-beta 1 protein would be needed as a cause of endothelial cell apoptosis in vivo. Future therapies against inappropriate vessel deletion in disease states may use the known gene-driven nature of apoptosis to modify this sort of cell death in endothelial cells.
引用
收藏
页码:35 / 49
页数:15
相关论文
共 72 条
[1]  
[Anonymous], HYPERTENSION PATHOPH
[2]   INSITU END-LABELING DETECTS DNA STRAND BREAKS IN APOPTOSIS AND OTHER PHYSIOLOGICAL AND PATHOLOGICAL STATES [J].
ANSARI, B ;
COATES, PJ ;
GREENSTEIN, BD ;
HALL, PA .
JOURNAL OF PATHOLOGY, 1993, 170 (01) :1-8
[3]   ROLE OF PROTEIN-KINASE-C IN THE INHIBITION BY FIBROBLAST GROWTH-FACTOR OF APOPTOSIS IN SERUM-DEPLETED ENDOTHELIAL-CELLS [J].
ARAKI, S ;
SIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (03) :1081-1085
[4]   INDUCTION OF APOPTOSIS BY HEMORRHAGIC SNAKE-VENOM IN VASCULAR ENDOTHELIAL-CELLS [J].
ARAKI, S ;
ISHIDA, T ;
YAMAMOTO, T ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (01) :148-153
[5]   APOPTOSIS OF VASCULAR ENDOTHELIAL-CELLS BY FIBROBLAST GROWTH-FACTOR DEPRIVATION [J].
ARAKI, S ;
SHIMADA, Y ;
KAJI, K ;
HAYASHI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1194-1200
[6]  
AZMI TI, 1984, LAB INVEST, V51, P206
[7]  
BALLARD FJ, 1985, J NUTR GROWTH CANCER, V2, P1
[8]   HIGH-GLUCOSE-TRIGGERED APOPTOSIS IN CULTURED ENDOTHELIAL-CELLS [J].
BAUMGARTNERPARZER, SM ;
WAGNER, L ;
PETTERMANN, M ;
GRILLARI, J ;
GESSL, A ;
WALDHAUSL, W .
DIABETES, 1995, 44 (11) :1323-1327
[9]   PRESSURE-INDEPENDENT ARTERIOLAR RAREFACTION IN HYPERTENSION [J].
BOEGEHOLD, MA ;
JOHNSON, MD ;
OVERBECK, HW .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (01) :H83-H87
[10]  
BOHLEN HG, 1986, HYPERTENSION, V8, P181, DOI 10.1161/01.HYP.8.3.181